4//SEC Filing
Caballa Susan 4
Accession 0001181431-12-008787
CIK 0001267602other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:25 PM ET
Size
7.5 KB
Accession
0001181431-12-008787
Insider Transaction Report
Form 4
Caballa Susan
SEE REMARKS
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-02-10+60,000→ 60,000 totalExercise: $1.65Exp: 2022-02-09→ Common Stock (60,000 underlying) - Award
Employee Stock Option (Right to Buy)
2012-02-10+25,000→ 25,000 totalExercise: $1.65→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]This option shall vest in forty-eight equal monthly installments beginning on March 10, 2012.
- [F2]This option shall vest in full upon receipt by the Issuer, on or prior to August 9, 2013, of approval from the U.S. Food and Drug Administration of the Issuer's New Drug Application for ILUVIEN (the "Vesting Event").
- [F3]This option shall expire on February 9, 2022, if the Vesting Event occurs. If the Vesting Event does not occur, then the option will expire on August 10, 2013.
Documents
Issuer
ALIMERA SCIENCES INC
CIK 0001267602
Entity typeother
Related Parties
1- filerCIK 0001489530
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:25 PM ET
- Size
- 7.5 KB